Neonatal Serum Deoxycorticosterone Sulfate Levels in Congenital Adrenal Hyperplasia due to 11β-Hydroxylase Deficiency
スポンサーリンク
概要
- 論文の詳細を見る
Recent studies have demonstrated that deoxycorticosterone sulfate can be formed at extra-adrenal sites, but its actual origin and role are not yet clear. The present study was undertaken to elucidate the origin of deoxycorticosterone sulfate and the usefulness of this steroid for the diagnosis of 11β-hydroxylase deficiency in the early neonatal period. We measured serum deoxycorticosterone sulfate levels during glucocorticoid therapy in an infant with 11β-hydroxylase deficiency. Before therapy, the serum deoxycorticosterone sulfate concentration at 6 days of life was higher than normal. Following glucocorticoid therapy, the serum deoxycorticosterone sulfate concentration showed a marked and dose-dependent suppression, as did the serum deoxycorticosterone and 11-deoxycortisol levels. These findings suggest that serum deoxycorticosterone sulfate can be used as another specific indicator for the diagnosis of 11β-hydroxylase deficiency in neonates, and that the adrenal glands may play an important role in neonatal deoxycorticosterone sulfate production under the control of ACTHrights:日本小児内分泌学会rights:本文データは学協会の許諾に基づきJournal Archiveから複製したものである
- 日本小児内分泌学会の論文
- 1993-00-00
日本小児内分泌学会 | 論文
- 43 Common origin of the Q258X mutation in StAR gene responsible for congenital aderenal lipoid hyperplasia in Japanese
- Recent Change in the Annual Incidence of Childhood Type 2 Diabetes in the Tokyo Metropolitan Area
- A Case of Acute Lymphoblastic Leukemia with Prader-Willi Syndrome during Growth Hormone Therapy
- Characteristics of a Fulminant Onset Form of Idiopathic Type 1 Diabetes Mellitus in Japanese Children
- Different Skeletal Phenotypes in a Mother and Two Daughters with Short Stature Homeobox-Containing Haploinsufficiency